Overview
A host of bipartisan benefits policy priorities await congressional action, including greater transparency and oversight of pharmacy benefit managers, new billing standards for healthcare providers, extended telehealth flexibilities, and urgently needed fixes to the new SECURE 2.0 retirement reforms.
Meanwhile, on the health side, regulators continue to issue guidance on numerous healthcare-related issues involving prescription drug data collection (RxDC) reporting, surprise billing and other transparency requirements, the Affordable Care Act’s preventive services mandate and essential health benefits categories, and association health plans. Additional mental health parity guidance is expected later this year, and several cases that may affect health benefits are winding through the courts.
On the retirement side, the agencies have released proposed regulations on the SECURE acts' eligibility rules for long-term part-time employees and a slew of other SECURE 2.0 guidance, including automatic enrollment, Roth employer contributions and in-plan emergency savings. And a Labor Department proposal seeking to expand the scope of fiduciary investment advice is facing criticism from Congress and some stakeholders.
The regulatory agenda also features executive compensation topics, including last-minute tips for companies filing their 2024 proxy statements and a look at the potential implications of the Delaware court ruling in the Tesla pay case.
Why attend
Learn about the latest federal and state policy developments affecting employee benefits and executive compensation, including compliance challenges and upcoming actions by Congress and the Biden administration, during this timely webinar.
Who should attend
Plan sponsors, HR professionals and others who need information on the latest federal and state policy developments affecting employee benefits and executive compensation, including compliance challenges and upcoming action in Congress and the Biden administration.
